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Abstract
To analyze the Involvement of rheumatoid factors (RF) in the generation of cryoglobullns and the
development of related tissue injuries, we have established a panel of antl-lgG2a RF mAbs
derived from MRL/MpJ-/pr/7pr (MRL-/pr), C3H/HeJ-/pr//pr, and 129/Sv mice. After Injection of
hybridoma cells to normal mice, all four lgG3 RF mAbs Induced cryoglobullnemia, and various
degrees of glomerulonephritis and skin leukocytoclastic vasculitis. In contrast, none of the RF
mAbs of the other Isotypes generated cryoglobullns or tissue lesions. Since the same
observation was obtained with another panel of five clonally related anti-lgG2a RF mAbs of
MRL-/pr origin with almost Identical heavy and light chain variable (V) regions but five different
Isotypes, it seems unlikely that the absence of pathogenicity of non-lgG3 RF mAbs was due to
differences in fine specificity or V framework regions. In addition, the analysis of serum RF In
MRL-/pr mice has demonstrated that a majority of 4 month old MRL-/pr mice produced substantial
amounts of lgG3 RF with cryoglobulln activity. Because the cryoglobulin activity is associated
with the murine lgG3 heavy chain constant region, RF of this subclass may play a significant role
in the development of autoimmune-related tissue injuries, especially In MRL-/pr mice.
Introduction
MRUMpJ-lpr/lpr (MRL-/pf) mice spontaneously develop a
lupus-like autoimmune syndrome characterized by immuno-
pathological manifestations such as necrotizing skin vasculitis and
glomerulonephritis (1,2). Remarkable features of this autoimmune
syndrome include production of IgG rheumatoid factors (RF),
responsible for the presence of intermediate-sized immune
complexes (3,4) similar to those found in the sera or synovial fluids
of patients with rheumatoid arthritis (5,6), and extremely large
amounts of cryoglobulins with a marked enrichment of the lgG3
subclass (7).
Recently we have shown that an lgG3 anti-lgG2a RF mAb,
6-19, derived from MRL-/pr mice is able to induce in normal
mice glomerulonephritis and skin leukocytoclastic vasculitis in
association with cryoglobulinemia (8,9). To further extend this
observation, we have analyzed if the association between RF and
cryoglobulin activities was of importance in the generation of
tissue injuries by studying the cryoprecipitability and pathogenicity
of a panel of anti-lgG2a RF mAbs of various isotypes, obtained
from unmanipulated MRUpr, C3HIHeJ-lpr/lpr (C3H-/pr), and
129/Sv mice. Our results indicate that cryoprecipitable lgG3
is the only pathogenic isotype of anti-lgG2a RF mAbs, when
injected into non-autoimmune mice, and that the majority of
sera from MRL-/pr mice exhibit RF of the lgG3 subclass
with cryoglobulin activity.
Methods
Mice
MRL-/pr, MRL- + / + , and CH3-/pr mice were purchased
from the Jackson Laboratory, Bar Harbor, ME. BALB/c
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and C57BL/6 mice were otained from Harlan Olac Ltd,
Oxfordshire, UK. (MRL-+/+ x BALB/c)F, (MRLxBALB) and
(C57BL/6 x BALB/c)F, (B6 x BALB) mice were bred in our own
animal facilities. Only female mice were used in this study.
Monoclonal RF
One IgM (10-2), three lgG1 (AM6, AM7 and 6-2), one lgG2a
(1-2D), five lgG2b (AM9, AM10, AM11, 2BE4, and 6-4), four lgG3
(6-19, AM16,1-10B4, and 5-7B), and one IgA (46-52) anti-lgG2a
RF mAbs were established from series of hybndomas from
unimmunized MRL-/pr or MRL-/pr.lghe mice, as described
previously (8,10,11). An lgG3 anti-lgG2a RF mAb (48-10) was
obtained from C3H-/pr mice (10). Six IgM anti-lgG2a RF mAbs
(A6504C12, A6506C7, A6506G5, A6507A10, A5705B8, and
A6605E10) were derived from unmanipulated 129/Sv mice (12).
Concentrations of IgM, IgA, and IgG subclasses in sera were
determined by IgM, IgA, and IgG isotype- and subclass-specific
ELISA as described (13).
In vivo treatment
To study the pathogenicity of our panel of anti-lgG2a RF mAbs,
Pristane-pretreated MRLxBALB or B6xBALB mice were
injected i.p. with 107 hybridoma cells and killed when moribund
(generally 7 - 1 2 days after the implantation of hybridomas). In
addition, BALB/c mice were injected i.p. with ascites containing
5 mg of lgG3 anti-lgG2a RF mAbs and killed after 18 h. The
macroscopic appearance of skin lesions was carefully noted.
Blocks of ear skin and kidneys were obtained at autopsy and
sections were stained with hematoxylin -eosin (HE) or periodic-
acid Schiff (PAS) for histopathological examination. Part of the
kidneys were studied for glomerular deposition of IgG by direct
staining with FITC-conjugated rabbit anti-mouse IgG (Cappel
Laboratories, Cochranville, PA).
Sera and cryoglobulins
Blood samples collected from the retro-orbital plexus were
allowed to clot at 37°C for 2 h. Sera were separated by
centrifugation and placed in glass tubes at 4°C for 3 days. Then,
sera were centrifuged at 3000 r.p.m. at 4°C for 10 min. The
supernatants were preserved, and the precipitates were washed
five times with cold PBS (pH 7.4) by centrifugation and finally
resolubilized in 4 M urea in the same volume as the original
sample.
Fluid-phase radioimmunoassay (RIA) for RF
The RF activity was assessed by a RIA as described previously
(8). Briefly, 50 /J of appropriately diluted serum samples was
incubated with 50 [A (1 /tg) of 125l-labeled heat-aggregated
pdyctonal murine IgG (AMG) overnight at 4°C. [)25I]AMG, bound
to RF, was precipitated and washed 3 times with PBS by
centrifugation at 1880 g for 5 min in a Beckman Microfuge
11 (Beckman Instruments Inc., Palo Alto, CA). The results are
expressed as a percentage of [125I]AMG precipitated. Studies
on a panel of anti-lgG2a RF mAbs of different Ig isotypes have
shown that only IgM and lgG3 RF mAbs efficiently precipitated
[12SI]AMG (T.Shibata etal. Clin. Exp. Immunol.).
ELISA for anti-lgG2a RF
Anti-lgG2a activities of RF mAbs were determined by ELISA as
described previously (9,10). In one study, microtiter plates were
initially coated with 5 /tg/ml of (4-hydroxy-3-iodo-5-nitrophenyf)
acetyl (NIP)-conjugated BSA, and then with 1 /xg/ml of lgG2a,X1
(NIP-23) anti-NIP mAb. Then, plates were incubated with
appropriately diluted sera and the assay was developed with
alkaline phosphatase-labeled rat anti-mouse x-chain mAb
(H139.52.1). In another study, microtiter plates were coated with
trinitrophenyl (TNP)-BSA, and subsequently incubated with
BALB/c lgG2a (Hy 1.2) anti-TNP mAb (lgh-1") or B6 lgG2a
(C4010F4) anti-TNP mAb (lgh-1"), prior to the addition of serum
samples. The assay was developed with alkaline phosphatase-
labeled goat anti-mouse IgM or rabbit anti-IgG subclass-specific
antibodies. For the detection of lgG2a anti-lgG2a RF activities,
sera from MRL-/pr mice (lgh-11) were incubated with plates
coated with TNP and B6 lgG2a anti-TNP mAb (lgh-1"), and the
assay was developed with enzyme-labeled anti-lgG2a mAb
(lg(1a)8.3) which is reactive with lgh-1', but not lgh-1b. Results
are expressed as the OD value at 405 nm.
cDNA cloning and sequencing
A cDNA library was produced from poly(A)+ RNA, prepared
from 6-19 hybridoma, with oligo(dT) primer, and a recombinant
plasmid, p6-19 clone 7.2, containing a full-length cDNA insert
was isolated, as described previously (9). The nucleotide
sequence corresponding to the 6-19 lgG3 heavy chain constant
(CT3) region of the plasmid clone insert was determined by
the dideoxynucleotide chain termination method (14), using
the Sequenase sequencing system (US Biochemical Corp.,
Cleveland, OH) with [a-^JdATP. The oligonucleotide primers
were as follows (5' — 31): M13 sequencing primer (GTA-
AAACGACGGCCAGT), CH1 primers (GGATAGACAGATGG)
complementary to codons 119-123 and (GCTGAGGGAATA-
GAACCC) (183 -188), CH2 primer (CCAGCTGACATGGACAT-
CTGGG) (283-290), CH3 primer (GTTGGTGACCAGGCAGG)
(389-394), and 3' UT CT3 primer (GACCCGAGGAATGGCT-
AGG). The oligonucleotide primers were synthesized with a
System 1 Beckman (Fullerton, CA) DNA synthesizer. V regions
of 10-2 (IgM), 6-2 (lgG1), 1-2D (lgG2a), 6-2 (lgG2b), and 5-7B
(lgG3) mAbs were sequenced from po)y(A)+ RNA as described
previously (15). The V region nucleotide sequences will be
described elsewhere (H. Shan era/., manuscript in preparation).
Results
In vivo pathogenicity of anti-lgG2a RF mAbs of various isotypes
We have previously demonstrated that the injection of an lgG3
anti-lgG2a RF mAb, 6-19, obtained from MRL-/pr mice induced
in normal mice glomerulonephritis and skin leukocytoclastic
vasculitis in association with cryoglobulinemia (8,9). To further
study the pathogenic activity of RF autoantibodies, a panel of
anti-lgG2a RF mAbs of different isotypes, including three lgG3
anti-lgG2a RF mAbs, either from unmanipulated MRL-Zpr,
C3H-/pr, or 129/Sv mice, were assessed for their pathogenic
activity in relation to the generation of cryoglobulins.
All three lgG3 anti-lgG2a RF mAbs (AM 16,1 -10B4, and 48-10)
obtained from three series of hybridomas were cryopreciprtable,
and each one of them was able to generate a characteristic
vascular purpura of the skin of exposed parts (ears, tail, footpads)
and an acute glomerulonephritis in MRLxBALB mice, similar
to those found in mice receiving the 6-19 hybridoma (Table 1
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Table 1. Development of skin vasculitis and glomerulonephritis after injection of hybridomas secreting lgG3 anti-lgG2a RF mAbs8
Isotype
IgM
lgG1
lgG2b
IgA
lgG3
mAb
A6504C12
A6506C7
A6506G5
A6507A10
A5705B8
A6605E10
AM6
AM7
AM9
AM10
AM11
2BE4
46-42
6-19
AM16
1-10B4
48-10
ig"
7.4
13.1
26.2
42 5
27.6
43.0
11.8
9.7
2.7
18.1
2.3
11.1
21.1
4.8
1.8
12.0
13.2
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
1 9
4.0
3.8
14.3
5.3
8.8
7.1
1.0
2.8
0.2
85
13.8
1.1
06
3 8
7.9
Cryoglobulins0
<0.1
<0 1
<0.1
<0.1
<0.1
<0 1
<0.1
<0.1
<0 1
<0.1
<0.1
21 ± 9
14 ± 3
55 ± 31
19 ± 8
Lesionsd
Skin
0/4
0/3
0/3
0/3
0/4
0/3
0/1
0/5
0/3
0/3
0/3
0/4
0/5
8/8
(3.6 ± 0.7)d
8/8
(2 8 ± 0.7)
2/5
(1.2 ± 1.6)
2/5
(0.4 ± 0.5)
Kidney
0/4
0/3
0/3
0/3
0/4
0/3
0/1
0/5
0/3
0/3
0/3
0/4
0/5
8/8
(3.8 ±
8/8
(1.9 ±
5/5
(3 4 ±
3/5
( 1 6 ±
0 5)d
10)
0.9)
1.5)
"Hybndoma ceils (107) were inoculated i.p. into MRLxBALB (for hybridomas of MRL- and C3H-/pr origins) or B6xBALB (for hybridomas of 129/Sv
ongin) mice. Animals were killed 7 -12 days later for serological and histological analysis.
bSerum levels of the Ig isotype of the mAbs secreted by each hybridoma, expressed as mg/ml (mean ± SD). Control values of each Ig isotype
were the following- IgM, 0.2 mg/ml; lgG1, 1.1 mg/ml; lgG2a, 3 8 mg/ml, lgG2b, 0 5 mg/ml; IgA, 1 5 mg/ml; lgG3, 0.1 mg/ml
°Serum levels of cryoglobulins Oig/ml) at death (mean ± SD). Note that cryopfedpitales isolated from sera of mice injected with lgG3 RF hybridomas
were composed almost exclusively of lgG3.
dlncidence of macroscopically visible skin lesions and of glomerulonephritis None of the mice injected with non-lgG3 RF hybridoma cells developed
significant skin or glomerular lesions. Semiquantitated values of skin and glomerular lesions induced by lgG3 RF mAbs on a 0 to 4 + scale based
on the intensity of each lesion are indicated in parentheses (mean ± SD).
and Fig. 1). However, the severity and incidence of both tissue
lesions varied in mice receiving different hybridoma: the 6-19
mAb was the most pathogenic mAb, and the 48-10 mAb was
the weakest. Although such differences could be in part related
to the differences in the capacity of each hybridoma cell line to
secrete lgG3 mAbs in vivo, the lack of correlation of the observed
pathology with serum levels of each lgG3 RF mAb suggested
that differences of pathogenicity were not solely related to
differences of serum levels of each lgG3 mAb studied. This was
further confirmed by the fact that there were significant differences
in glomerular IgG deposits after the injection of ascites containing
the same amount (5 mg) of each lgG3 anti-lgG2a RF mAb: the
strongest IgG deposits were observed with the 6-19 and 1-10B4
mAbs, followed by the AM 16 mAb. Only minimal deposits were
seen in mice receiving the 48-10 mAb.
The observed differences in nephritogenicity of the various
lgG3 RF mAbs were not apparently due to an abnormality of
the CT3 region, because the nucleotide sequence analysis of
the 6-19 cDNA clone did not demonstrate any mutation in its
CT3 region, whose nucleotide sequence is identical to the
published BALB/c lgG3 germline sequence (16) (data not
shown). However, the 6-19 cDNA clone, and also other lgG3
mAbs derived from BALB/c, C57BL/6,129/Sv, and MRL mouse
strains (unpublished data), were found to contain an additional
codon (GCT encoding an alanine), which is present in the BALB/c
germline sequence 5' to the expected splice site (codon 114).
In contrast to the remarkable pathogenic activity of all lgG3
RF mAbs, no RF mAb from any Ig isotype (IgM, lgG1, lgG2b,
or IgA) studied other than lgG3 was able to cryoprecipitate and
to elicit either skin or glomerular lesions in any single mouse
(Table 1). This was not due to low circulating levels of the mAbs
secreted by the hybridomas, as serum Ig levels were significantly
enriched in the isotype of the mAbs secreted by each hybridoma.
Pathogenicity of different isotypes of clonally related anti-lgG2a
RF mAbs
To rule out the possibility that the observed isotype-related
differences in pathogenicity are due to differences in fine
specificities or framework regions (FR) of the V domains, we have
established another panel of antj-lgG2a RF mAbs from one single
unmanipulated MRL-lpr mouse and selected five clonally related
RF mAbs of various isotypes (IgM, lgG1, lgG2a, lgG2b, and
lgG3) exhibiting almost identical VH and VL nucleotide
sequences. In fact, there was a maximum of six amino acid
differences in each V region between the 5-7B lgG3 anti-lgG2a
RF mAb and the mAbs of the other isotypes (Table 2).
When their pathogenicity was studied by injecting MRLx BALB
mice i.p. with hybridoma cells secreting these mAbs, the 5-7B
lgG3 RF mAb was again the only one able to cryoprecipitate
and to generate the characteristic skin and glomerular lesions.
In contrast, 10-2 (IgM), 6-2 (lgG1), 1-2D (lgG2a), and 6-4
(lgG2b) mAbs induced neither cryoglobulinemia nor significant
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Fig. 1. (A) and (B) Representative histological appearance of skin lesions of ears 10 days after the i p. injection of AM 16 lgG3 RF hybndoma cells
into MRL x BALB mice. Leukocytoclastic vasculitis was characterized by the infiltration of polymorphonuclear leukocytes and the extravasation of
erythrocytes. (HE; A: x 60; B: x 240.) (C) Absence of leukocytoctastic vascular lesions in skin of ears from mice injected with hybridoma cells secreting
the 1-2D lgG2a RF mAb. (HE; x60.) (D) and (E) Representative histokxjical appearance of glomerular lesions induced by the AM16 lgG3 RF mAb
showing the proliferative and exudative changes (D) and the deposition of PAS-positive material along the glomerular capillary walls (E, arrows)
Note a marked enlargement of glomeruli as compared with those (F) from mice injected with non-pathogenic 1-2D lgG2a RF hybridoma cells. (D:
HE, x 120; E: PAS, x240.) (F) Representative histologicaJ appearance of kidneys after the i.p. injection of 1-2D lgG2a RF hybridoma cells. Note
the absence of significant glomerular changes. (PAS, x240.)
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tissue lesions of any kind, in spite of marked enrichment of
the corresponding Ig isotype for each mAb injected and of
comparable or even higher activities of anti-lgG2a RF in the
circulating blood (Table 3).
Cryoglobulin activities of RF in sera from MRL-lpr mice
Since our studies on a panel of anti-lgG2a RF mAbs have
demonstrated that their pathogenic activity is associated with
lgG3 cryoglobulin activity, we have investigated the extent of
cryoglobulin and RF association in MRL-lpr mice. To study this,
RF activities in whole sera and in sera depleted of cryoglobuhns
from 4 month old MRL-/pr mice were assessed by fluid-phase
RIA, which efficiently detects IgM and lgG3 classes of RF. RF
activities markedly diminished in the majority of sera after removal
of cryoglobulins (Fig. 2). In fact, mean values of [125I]AMG
precipitating activities by 10 ^ 1 of sera dropped from 49.9 ±12.3
to 16.8 ± 16.5%. Quantitative studies by serial dilution of sera
showed that 18 of 20 samples from 4 month old MRL-lpr mice
exhibited a >50% decrease in RF activities detectable by RIA
after cryoglobulin elimination. When Ig isotypes of anti-lgG2a RF
were analyzed by ELISA, in four out of five mice tested, only the
Table 2. Differences in the amino acid sequences of four
anti-lgG2a RF mAbs clonally related to the lgG3 5-7B RF mArj8
mAb
10-2
6-2
1-2D
6-4
Isoptype
IgM
lgG1
lgG2a
lgG2b
vH
0"
-
6
CDR1,
4
CDR1,
1
CDR2
CDR2,
CDR2,
FR1, FR2
FR2
vL
1 b
CDR1C
1
CDR1
4
CDR1,
4
CDR1,
CDR2, CDR3
CDR3
aV region ammo acid sequences were deduced from the nucleotide
sequences of mRNA encoding VH and V,, regions of anti-lgG2a RF
mAbs.
bNumber of amino acid substitutions in comparison with the
corresponding V regions of the 5-7B lgG3 antMgG2a RF mAb.
cLocation of ammo acid substitutions in comparison with the
corresponding V regions on the 5-7B lgG3 anti-lgG2a RF mAb.
lgG3 subclass was selectively diminished in RF after removal of
cryoglobulins from the sera of MRL-lpr mice. Representative
results are shown in Fig. 3. This indicated that lgG3 RF were
indeed associated with cryoglobulins in MRL-lpr mice.
Discussion
In the present study, using a panel of anti-lgG2a RF mAbs derived
either from unmanipulated MRL-lpr, C3H-/p/-, or 129/Sv mice,
we have demonstrated that only RF mAbs that are able to
cryoprecipitate—all from the lgG3 subclass—can induce skin
vasculitis and glomerulonephritis. Furthermore, we have shown
that substantial amounts of cryoprecipitable lgG3 RF activities
were detected in lupus-prone MRL-lpr mice.
The notion that Ig cryoprecipitability, which is associated with
the lgG3 subclass, can promote the pathogenic activity of RF
autoantibodies is strongly suggested by our observation that all
five cryoprecipitable lgG3 anti-lgG2a RF mAbs tested, derived
from five different series of hybridomas of MRL- and C3H-lpr
origins, are able to induce severe skin vascular lesions and
glomerulonephritis in normal mice, whereas no RF of the same
specificity but of a different Ig isotype lacking the cryoglobulin
activity can provoke such lesions. It is unlikely that differences
in fine specificities or FR sequences of the V region may account
for the absence of pathogenicity observed with RF mAbs of Ig
isotypes other than lgG3. In fact, in a panel of anti-lgG2a RF
mAbs of five different isotypes (IgM, lgG1, lgG2a, lgG2b, and
lgG3), apparently from the same clonal origin with almost identical
V region sequences, the lgG3 RF mAb was again the only one
able to generate cryoglobulins and tissue lesions.
The lesions observed in mice injected with lgG3 RF mAbs were
similar to one another and have already been described in
previous studies for one of these mAbs, clone 6-19 (8,9).
However, there exists some individual variability in the extent to
which each lgG3 RF mAb induces skin vasculitis or glomerulo-
nephritis, some mAbs being more pathogenic for glomerular
and/or vascular lesions than others. At present, we do not have
a good explanation for these differences. However, since RF
activity appears to be critically involved in the generation of
leukocytoclastic vasculitis induced by the lgG3 RF mAbs (9),
Table 3. Pathogenicity of different isotypes of five clonally related anti-lgG2a RF mAbs8
Isotype
IgM
IgGi
lgG2a
lgG2b
lgG3
mAb
10-2
6-2
1-2D
6-4
5-7B
16.9 ± 4.9
8.5 ± 1 0
15 8 ± 7.2
16.6 ± 2.0
6.1 ± 1.7
RF0
>2.000
1.394 ± 0.161
0.774 ± 0.535
1.484 ± 0.155
0.933 ± 0.137
Cryoglobulinsd
<0.1
<0.1
<0.1
<0.1
29 ± 10
Lesions8
Skin
0/4
0/5
0/5
0/3
5/7
(1.7 ± 1.4)"
Kidney
0/4
0/5
0/5
0/3
7/7
(3.9 ± 0.4)"
aHybridoma cells (107) were inoculated i.p. into MRL x BALB mice. Animals were killed 7 -12 days later for serological and histological analysis.
"See Table 1.
cSerum anti-lgG2a RF activities were determined by ELISA. Microtiter plates coated with NIP-BSA and lgG2a anti-NIP mAb (NIP-23) were
incubated with serum samples at a 1:25,000 dilution, and the assay was developed with alkaline phosphatase-labeled rat anti-mouse x-chain mAb
(H139.52.1). Results are expressed as the OD value at 405 nm. Control values at a 1:1000 dilution prior to the hybridoma injection were 0.055 ± 0.010
(mean of five mice ± SD).
dSee Table 1.
"See Table 1.
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differences in pathogenic potential of each lgG3 RF mAb may
be in part related to possible differences of affinity of RF
autoantibodies. In addition, it should be noted that although
the nephritogenic activity of the 6-19 RF mAb is apparently
determined only by its cryoglobulin activity (9), serum levels of
cryoglobulins in mice receiving different lgG3 RF mAbs did not
correlate well with the severity of glomerular lesions and not all
lgG3 cryoglobulins lacking RF activity were able to induce
glomerular lesions (8.17). This suggests that qualitative features,
such as conformation and/or temperature dependency, of
cryoglobulins may be critical in the nephritogenic activity of lgG3
cryoglobulins. Since we did not find any mutations in the CT3
region of the most pathogenic 6-19 mAb, V region sequences
are likely to determine the pathogenicity of lgG3 cryoglobulins.
In this context, it should be mentioned that the electrostatic
charges in the V regions can markedly influence the cryoglobulin
activity of lgG3 (18). Accordingly, the introduction of new charged
amino acid residues as a result of somatic mutations occurring
during the course of autoimmune responses, as shown in the
case of anti-DNA antibodies for MRL-lpr mice (19), may create
more pathogenic cryogenerating autoantibodies.
The selective pathogenicity of RF mAb of the cryoprecipitable
lgG3 subclass is significant, because cryoglobulins have long
been suggested to be a potential source of tissue injuries in
systemic lupus erythematosus, rheumatoid arthritis, and related
autoimmune diseases (20). Extensive light and electron micro-
scopic studies have shown that glomerular lesions induced
by the 6-19 lgG3 RF mAb resemble 'wire-loop' lesions, i.e.
subendothelial accumulation of electron-dense deposits,
characteristically described for lupus nephritis (17). In addition
to lgG3 RF mAbs, we have recently observed that an lgG3
anti-DNA mAb derived from (NZB x NZV^F, hybrid mice is
able to induce similar glomerular lesions (17). Thus, lgG3
autoantibodies with cryoglobulin activity, independently of their
immunological specificities, may participate in the pathogenesis
of lupus nephritis. In fact, recent studies on MRL-lpr and
Before After
Fig. 2. Comparison of serum RF activities before and after removal of
cryoglobulins in 4 month old MRL-lpr mice. Whole sera or sera depleted
of cryoglobulin (10/J) were incubated with 1 ^ g of [125I]AMG at 4°C
overnight. Results are expressed as percent precipitation of (125I]AMG.
MRL-lpr x (MRL-lpr x CH3-/pr) backcross mice have shown a
good correlation of lgG3 production with the development of
glomerular lesions, and selective enrichment of lgG3 in renal
eluates from diseased kidneys (21). The pathogenic importance
of lgG3 cryoglobulins can be further supported by the fact that
the transfer of the xid gene, which causes a defect of IgM and
lgG3 production, delayed the development of lupus nephritis in
autoimmune mice including MRL-tpr mice (22). Finally, it should
be mentioned that all human lgG3 myeloma proteins studied
by Capra and Kunkel (23) undergo a concentration- and
temperature-dependent aggregation, and that some lgG3
myeloma proteins with RF activity are indeed able to generate
cryoglobulins (24,25). The detection of lgG3 RF in relation to
cryoglobulin activity may be a useful and predictive indicator of
the course of seropositive rheumatoid arthritis.
IgM »nu-IgG2* IgGl inti-IgG2a
C IgG2a tnu-IgG2«
IT
D IgG2b mn'-IgG2a
21
E
 IgG3 inti-lgG2i
2i
1/200 1/1000 1/3000
Serum (dilution)
F
 R I A
501
1/200 1/1000 1/3000
Serum (dilution)
Fig. 3. Comparison of serum anti-lgG2a RF activities before (O) and
after ( • ) removal of cryoglobulins from a 4 month old MRL-lpr mouse.
(A), (B), (D), and (E): microtiter plates coated with TNP - BSA and lgG2a
anti-TNP mAb (Hy 1.2) (iQh-i3) were incubated with serially diluted serum
samples, and the assay was developed with alkaline phosphatase-tabeled
goat anti-mouse IgM or rabbit anti-lgGi, lgG2b, or lgG3 antibodies. (C):
microtiter plates coated with TNP - BSA and lgG2a anti-TNP (C4010F4)
(lgh-115) were incubated with serum samples, and the assay was
developed with enzyme-labeled anti-lgG2a mAb (lg(1a)8.3) which is
reactive with lgG2a of MRL-lpr mice (lgh-1*), but not with lgG2a of the
lgh-1b allotype. Results of ELISA (A - E) are expressed as the OD value
at 405 nm. (F): fluid-phase RIA Various amounts of whole sera or sera
depleted of cryoglobulins were incubated with 1 pg of [125IJAMG at 4°C
overnight. Results are expressed as percent precipitation of [125I]AMG.
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